Primus In News
Shipping bottlenecks squeeze pharma flows as Hormuz crisis impact deepens
14-04-2026
Nilaya Varma, Co-Founder and Group CEO, Primus Partners, shares his view on how geopolitical tensions are driving up input costs in India’s pharma sector due to heavy reliance on Chinese APIs and vaccine raw materials, delaying shipments and straining exports to Gulf and emerging markets
Explore Related Insights
- Social media addiction, sedentary habits eating into health, productivity potential: Economic Survey
- Electric 2-wheeler cos await surge in warranty claim
- Cabinet okays ₹10,738 crore PLI scheme for solar modules, white goods
- Union Budget 2022: Finance minister announces Digital University, e-content in regional languages
